Matches in Wikidata for { <http://www.wikidata.org/entity/Q85183955> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q85183955 description "2010 թվականի հոկտեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q85183955 description "article scientifique publié en 2010" @default.
- Q85183955 description "artículu científicu espublizáu n'ochobre de 2010" @default.
- Q85183955 description "scientific article published on 12 October 2010" @default.
- Q85183955 description "wetenschappelijk artikel" @default.
- Q85183955 description "наукова стаття, опублікована в жовтні 2010" @default.
- Q85183955 name "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 name "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 type Item @default.
- Q85183955 label "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 label "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 prefLabel "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 prefLabel "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 P1433 Q85183955-C0133C9F-94B5-45A1-A489-8DD6865C7E95 @default.
- Q85183955 P1476 Q85183955-65FCEDC9-1BBE-4675-8462-DB096753C9BD @default.
- Q85183955 P2093 Q85183955-1BB6A6D6-606D-4183-A189-C62B5C5AB124 @default.
- Q85183955 P2093 Q85183955-1E8D85D3-D945-47A8-9232-C09FD0F0A971 @default.
- Q85183955 P2093 Q85183955-3DCD33DA-4753-4236-A5C1-D33A01CD9648 @default.
- Q85183955 P2093 Q85183955-4D248651-6B88-42CE-9693-08BCE4066232 @default.
- Q85183955 P2093 Q85183955-5572F257-7B3D-4273-BD33-D4FC84D24F00 @default.
- Q85183955 P2093 Q85183955-5E4F06A4-AB34-48E5-819A-81CF0E5516E5 @default.
- Q85183955 P2093 Q85183955-6489C931-6BEE-498E-9CD3-CDD59577F0BA @default.
- Q85183955 P2093 Q85183955-846A4AE7-B1FC-41ED-93F8-0569892EFAD6 @default.
- Q85183955 P2093 Q85183955-A264E68F-21C1-4B13-8412-6E99B572F19F @default.
- Q85183955 P2093 Q85183955-A5D142CD-00EA-42D6-8F6D-630B13DB3C71 @default.
- Q85183955 P2093 Q85183955-AEB6F52B-DA46-4FC1-B1BD-07EEBEBDCDBB @default.
- Q85183955 P2093 Q85183955-B5E3FE67-AFB9-4966-8350-C1944A9CC54C @default.
- Q85183955 P2093 Q85183955-C6E8BE0A-CAA8-44EA-8640-59DA42F2A855 @default.
- Q85183955 P2093 Q85183955-DFB6F44E-ABE7-46F2-AFC9-54804059FC21 @default.
- Q85183955 P2093 Q85183955-EECE408B-6ADE-4A7F-B42F-6BB02C2DB51F @default.
- Q85183955 P304 Q85183955-BC8ED055-F835-4E75-B497-FE5F442DE9C9 @default.
- Q85183955 P31 Q85183955-7C5B6713-255B-4737-B85C-FE293F9C677E @default.
- Q85183955 P356 Q85183955-29E9ACE7-AD54-4206-A3D1-9D66BD6A2B12 @default.
- Q85183955 P433 Q85183955-682E8187-0EDB-46B0-B4CB-3F949A76B491 @default.
- Q85183955 P478 Q85183955-573E4517-0E09-477E-B490-C94366E055BC @default.
- Q85183955 P577 Q85183955-8B5E52D3-C0F6-4671-9D03-8DA10A39FBCA @default.
- Q85183955 P698 Q85183955-497D36FD-7F68-4258-B256-DE42C5903DE7 @default.
- Q85183955 P921 Q85183955-62F0B631-BD9F-4CA8-88FC-3C2331573FCA @default.
- Q85183955 P921 Q85183955-F52E5977-BDFF-4E8B-9C27-F110C272B765 @default.
- Q85183955 P356 0091270010373930 @default.
- Q85183955 P698 20940336 @default.
- Q85183955 P1433 Q7743562 @default.
- Q85183955 P1476 "Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers" @default.
- Q85183955 P2093 "Alain Patat" @default.
- Q85183955 P2093 "Allyson Masci" @default.
- Q85183955 P2093 "Claire Toutin" @default.
- Q85183955 P2093 "Edward Mascioli" @default.
- Q85183955 P2093 "Eric Lacoste" @default.
- Q85183955 P2093 "Eric Zanelli" @default.
- Q85183955 P2093 "Gwenola Gandon" @default.
- Q85183955 P2093 "Jeffrey Krieger" @default.
- Q85183955 P2093 "Joseph Kovalchin" @default.
- Q85183955 P2093 "Kathy Collins" @default.
- Q85183955 P2093 "Michael Augustyniak" @default.
- Q85183955 P2093 "Michelle Genova" @default.
- Q85183955 P2093 "Nicolas Fauchoux" @default.
- Q85183955 P2093 "Tony Avril" @default.
- Q85183955 P2093 "Uday Patel" @default.
- Q85183955 P304 "649-660" @default.
- Q85183955 P31 Q13442814 @default.
- Q85183955 P356 "10.1177/0091270010373930" @default.
- Q85183955 P433 "5" @default.
- Q85183955 P478 "51" @default.
- Q85183955 P577 "2010-10-12T00:00:00Z" @default.
- Q85183955 P698 "20940336" @default.
- Q85183955 P921 Q323936 @default.
- Q85183955 P921 Q725307 @default.